Last reviewed · How we verify
Insulin LISPRO intravenous loading
Insulin LISPRO intravenous loading is a Small molecule drug developed by Rambam Health Care Campus. It is currently FDA-approved. Also known as: Humalog Insulin.
Insulin LISPRO intravenous loading is used to study its effects on conditions such as Diabetes Mellitus, Ventricular Dysfunction, and Diabetic Neuropathy. The treatment is administered intravenously as part of clinical trials to investigate its impact on patients with these conditions.
At a glance
| Generic name | Insulin LISPRO intravenous loading |
|---|---|
| Also known as | Humalog Insulin |
| Sponsor | Rambam Health Care Campus |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Insulin Effects on Cardiac Function in Patients With Diabetes Mellitus (PHASE4)
- Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Insulin LISPRO intravenous loading CI brief — competitive landscape report
- Insulin LISPRO intravenous loading updates RSS · CI watch RSS
- Rambam Health Care Campus portfolio CI
Frequently asked questions about Insulin LISPRO intravenous loading
What is Insulin LISPRO intravenous loading?
Who makes Insulin LISPRO intravenous loading?
Is Insulin LISPRO intravenous loading also known as anything else?
What development phase is Insulin LISPRO intravenous loading in?
Related
- Manufacturer: Rambam Health Care Campus — full pipeline
- Also known as: Humalog Insulin
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing